Cargando…

Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study

BACKGROUND AND OBJECTIVE: Moyamoya disease (MMD) is an increasingly recognised cause of stroke, mainly described in East Asia. China is the largest nation in Asia, but few studies reported the epidemiology of MMD, especially at a national level. We aimed to estimate the incidence and prevalence of M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yixin, Zhou, Guoyu, Feng, Jingnan, Chen, Lu, Liu, Guozhen, Wang, Jinxi, Wang, Qingliang, Yu, Junyou, Yang, Xiwang, Yang, Zheng, Gao, Pei, Wang, Shengfeng, Zhan, Siyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717778/ https://www.ncbi.nlm.nih.gov/pubmed/33941642 http://dx.doi.org/10.1136/svn-2021-000909

Ejemplares similares

Incidence of and trends in hip fracture among adults in urban China: A nationwide retrospective cohort study
por: Zhang, Chenggui, et al.
Publicado: (2020)

Prevalence of mammary Paget’s disease in urban China in 2016
por: Xu, Lu, et al.
Publicado: (2021)

Increasing prevalence and burden of bronchiectasis in urban Chinese adults, 2013–2017: a nationwide population-based cohort study
por: Feng, Jingnan, et al.
Publicado: (2022)

Prevalence of extramammary Paget’s disease in urban China: a population-based study
por: Yin, Shilu, et al.
Publicado: (2021)

Prevalence and Incidence of Multiple Myeloma in Urban Area in China: A National Population-Based Analysis
por: Wang, Shengfeng, et al.
Publicado: (2020)

Incidence of gastrointestinal stromal tumor in Chinese urban population: A national population‐based study
por: Xu, Lu, et al.
Publicado: (2020)

Incidence and cost of haemolytic uraemic syndrome in urban China: a national population-based analysis
por: Feng, Jingnan, et al.
Publicado: (2022)

The Cohort Study on Prediction of Incidence of All-Cause Mortality by Metabolic Syndrome
por: Li, Zhixia, et al.
Publicado: (2016)

Impact of the COVID-19 Pandemic on Outpatient Service in Primary Healthcare Institutions: An Inspiration From Yinchuan of China
por: Xu, Lu, et al.
Publicado: (2021)

Estimating mortality among inpatients with acute exacerbation of chronic obstructive pulmonary disease using registry data
por: Pei, Zhengcun, et al.
Publicado: (2020)

Epidemiology of Moyamoya disease in China: A nationwide hospital-based study
por: Zhang, Dong, et al.
Publicado: (2021)

Appropriateness of Antibiotic Prescriptions in Chinese Primary Health Care and the Impact of the COVID-19 Pandemic: A Typically Descriptive and Longitudinal Database Study in Yinchuan City
por: Zhao, Houyu, et al.
Publicado: (2022)

Sex-specific associations between lipids and cognitive decline in the middle-aged and elderly: a cohort study of Chinese adults
por: Liu, Lili, et al.
Publicado: (2020)

Moyamoya Syndrome: A Window of Moyamoya Disease
por: Phi, Ji Hoon, et al.
Publicado: (2015)

Trends in Psychotropic Medication Prescriptions in Urban China From 2013 to 2017: National Population-Based Study
por: Xu, Lu, et al.
Publicado: (2021)

Imaging of Moyamoya Disease and Moyamoya Syndrome: Current Status
por: Li, Jincheng, et al.
Publicado: (2019)

Prevalence and Epidemiological Features of Moyamoya Disease in Korea
por: Yim, Sang Hyuk, et al.
Publicado: (2012)

MicroRNA Expression in Circulating Leukocytes and Bioinformatic Analysis of Patients With Moyamoya Disease
por: Kang, Kaijiang, et al.
Publicado: (2022)

Association of Brain-Gut Peptides with Inflammatory Cytokines in Moyamoya Disease
por: Han, Wenxiu, et al.
Publicado: (2020)

Associations between pulmonary function and cognitive decline in the middle-aged and older adults: evidence from the China Health and Retirement Longitudinal Study
por: Lai, Xuefeng, et al.
Publicado: (2022)

Incidence and Survival of Aortic Dissection in Urban China: Results from the National Insurance Claims for Epidemiological Research (NICER) Study
por: Tang, Xun, et al.
Publicado: (2021)

Postoperative cerebral infarction after revascularization in patients with moyamoya disease: Incidence and risk factors
por: Wang, Jiaxiong, et al.
Publicado: (2022)

Difference in Cerebral Circulation Time between Subtypes of Moyamoya Disease and Moyamoya Syndrome
por: Kang, Kaijiang, et al.
Publicado: (2017)

Obesity and risk of hearing loss in the middle-aged and elderly: a national cohort of Chinese adults
por: Zhang, Chen, et al.
Publicado: (2023)

Accuracy of Commercial Molecular Diagnostics for the Detection of Pulmonary Tuberculosis in China: A Systematic Review
por: Deng, Siwei, et al.
Publicado: (2019)

Indirect revascularization vs. non-surgical treatment for Moyamoya disease and Moyamoya syndrome: A comparative effectiveness study
por: Wang, Yixuan, et al.
Publicado: (2022)

Moyamoya Biomarkers
por: Smith, Edward R.
Publicado: (2015)

The Effects of Cardiometabolic Factors on the Association Between Serum Uric Acid and Chronic Kidney Disease in Chinese Middle-Aged and Older Population: A Mediation Analysis
por: Xu, Lu, et al.
Publicado: (2021)

Social deprivation and secondhand smoke exposure among urban male residents: A nationwide study in China
por: Yang, Yixin, et al.
Publicado: (2021)

The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya
por: Bao, Xiang-Yang, et al.
Publicado: (2022)

Electroencephalographic features in pediatric patients with moyamoya disease in China
por: Lu, Jia, et al.
Publicado: (2020)

Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease
por: MIKAMI, Takeshi, et al.
Publicado: (2019)

Research Progress of Moyamoya Disease in Children
por: Piao, Jianmin, et al.
Publicado: (2015)

Variations in Incidence and Prevalence of Parkinson's Disease in Taiwan: A Population-Based Nationwide Study
por: Liu, Chih-Ching, et al.
Publicado: (2016)

Application of DTI and fMRI in moyamoya disease
por: Hao, Xiaokuan, et al.
Publicado: (2022)

Metabolomic Profiling Revealed Potential Biomarkers in Patients With Moyamoya Disease
por: Geng, Chunmei, et al.
Publicado: (2020)

Pediatric Moyamoya disease
por: Nagiub, Mohamed, et al.
Publicado: (2013)

Moyamoya: An Update and Review
por: Berry, James A, et al.
Publicado: (2020)

Editorial: Moyamoya disease
por: Gu, Yuxiang
Publicado: (2022)

Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study
por: Seo, Woo‐Keun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nstrkh3oufdneksr2178t2l5eg